Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
It addresses the medical condition of low T rather than performance enhancement
Because the pivotal efficacy trials pit CagriSema against semaglutide, they are designed to show what cagrilintide adds to a GLP-1 backbone, not what cagrilintide does on its own to gastric physiology
One trial evaluated TB4 for heart health, finding that the peptide could protect and repair the heart in patients with acute myocardial infarction, and a separate trial found that TB4 improved outcomes during congenital heart surgery.21 The review also mentions a few clinical trials related to eye health, with results showing that TB4 can reduce eye dryness, relieve ocular discomfort, lower inflammation in the conjunctiva, and more
For dosing context, see the DSIP dosing guide
Dosage Protocols Units assume a 50 mg vial in 2 mL of bacteriostatic water (25 mg/mL), so 1 unit = 0.25 mg
